Idera Pharmaceuticals Acquires Aceragen
28 sept. 2022 16h09 HE
|
Idera Pharmaceuticals, Inc.
Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024 Conference call and webcast today at 5:00...